Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CT Providers

Dr. Stephanie Halene, MD

Accepting New Patients

(No ratings)

Specializes in: Adult Hematology

Professional interests include: blood disorders, leukemia, thrombosis (blood clots), and more.

35 Park Street
New Haven, CT 06519

(203) 785-2140

Dr. Stephanie Halene, MD is an adult hematologist in New Haven, CT specializing in adult hematology. Dr. Stephanie Halene, MD is affiliated with Yale University, Yale New Haven Health and Smilow Cancer Hospital, Yale Medicine.

Office Locations

Address:

35 Park Street
New Haven, CT 06519

Address:

800 Howard Avenue Yale Physicians Building
New Haven, CT 06519

Some issues Dr. Stephanie Halene, MD can help you with:

Thrombocytopenia (Low Platelet Count)

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

If a doctor suspects a patient has a thrombocytopenia, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytopenia can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Many people with thrombocytopenia can live healthy and fulfilling lives with proper treatment and precautions.

Thrombocytosis (High Platelet Count)

Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:

Thrombocythemia, also referred to as primary or essential thrombosis (ET), develops from irregular bone marrow cells that produce too many platelets. The cause of these bone marrow cells is unknown.
Reactive thrombosis (RT), also referred to as secondary thrombosis, arises from a different condition such as cancer, anemia, spleen removal, or infection. It is most common in older adults, but can occur in people of all ages. Symptoms of reactive thrombosis may gradually develop over time and typically include bruising, gum bleeding, and blood clotting.

If a doctor suspects a patient has thrombocytosis, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytosis can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin to thin the blood. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with thrombocytosis are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with thrombocytosis live healthy and fulfilling lives with proper treatment and precautions.

In The News (see more mentions in the news)

“Giulia Biancon, postdoctoral associate in the Halene Lab, was the lead author of the study along with senior authors Toma Tebaldi, past adjunct assistant professor at the School of Medicine, and...”—"New Yale study shows potential target for treating blood cancers", Yale News, March 2022

“Dr. Stephanie Halene, chief of hematology at the Yale Cancer Center, was not surprised at the different colors of the bags in the photo.”—"COVID-19 vaccines do not change color of blood", Associated Press News, September 2021

“* Stephanie Halene, MD, PhD, has been appointed Chief of Hematology at Yale Cancer Center, Smilow Cancer Hospital and the Yale School of Medicine Department of Internal Medicine.”—"Area people of note, Jan. 17, 2021", New Haven Register, January 2021

hospital care	141
inpatient care	141

**Gender**
Male	27
Female	26

**Ethnicity**
Non-Hispanic White	32
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	19
From 75 to 84	0
85 and over	0
Less than 65	21

Hypertension	75
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	42
Depression	43
Chronic Kidney Disease	66
Asthma	23
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	43
Chronic Obstructive Pulmonary Disease	40
Diabetes	30
Dementia	21
Cancer	0

hospital care	285
inpatient care	285

**Gender**
Male	51
Female	40

**Ethnicity**
Non-Hispanic White	65
Black	15
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	39
From 75 to 84	0
85 and over	0
Less than 65	27

Hypertension	75
High Cholesterol	49
Stroke	19
Ischemic Heart Disease	36
Depression	44
Chronic Kidney Disease	67
Asthma	15
Osteoperosis	0
Atrial Fibrilation	24
Heart Failure	34
Chronic Obstructive Pulmonary Disease	22
Diabetes	35
Dementia	14
Cancer	15

hospital care	368
inpatient care	368

**Gender**
Male	104
Female	100

**Ethnicity**
Non-Hispanic White	156
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	74
From 75 to 84	46
85 and over	22
Less than 65	62

Hypertension	75
High Cholesterol	59
Stroke	17
Ischemic Heart Disease	53
Depression	55
Chronic Kidney Disease	73
Asthma	23
Osteoperosis	0
Atrial Fibrilation	23
Heart Failure	51
Chronic Obstructive Pulmonary Disease	34
Diabetes	35
Dementia	23
Cancer	15

hospital care	182
inpatient care	182

**Gender**
Male	28
Female	49

**Ethnicity**
Non-Hispanic White	53
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	24
From 75 to 84	24
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	60
Stroke	21
Ischemic Heart Disease	53
Depression	48
Chronic Kidney Disease	68
Asthma	32
Osteoperosis	0
Atrial Fibrilation	27
Heart Failure	53
Chronic Obstructive Pulmonary Disease	26
Diabetes	39
Dementia	29
Cancer	19

hospital care	290
inpatient care	290

**Gender**
Male	40
Female	41

**Ethnicity**
Non-Hispanic White	55
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	46
From 75 to 84	0
85 and over	0
Less than 65	16

Hypertension	75
High Cholesterol	48
Stroke	0
Ischemic Heart Disease	54
Depression	43
Chronic Kidney Disease	75
Asthma	0
Osteoperosis	0
Atrial Fibrilation	21
Heart Failure	41
Chronic Obstructive Pulmonary Disease	21
Diabetes	40
Dementia	27
Cancer	0

hospital care	301
inpatient care	301

**Gender**
Male	46
Female	57

**Ethnicity**
Non-Hispanic White	69
Black	19
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	41
From 75 to 84	32
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	67
Stroke	15
Ischemic Heart Disease	53
Depression	44
Chronic Kidney Disease	75
Asthma	14
Osteoperosis	0
Atrial Fibrilation	23
Heart Failure	47
Chronic Obstructive Pulmonary Disease	29
Diabetes	44
Dementia	20
Cancer	22

hospital care	219
inpatient care	219

**Gender**
Male	38
Female	38

**Ethnicity**
Non-Hispanic White	56
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	29
From 75 to 84	21
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	62
Stroke	0
Ischemic Heart Disease	58
Depression	43
Chronic Kidney Disease	75
Asthma	0
Osteoperosis	0
Atrial Fibrilation	18
Heart Failure	59
Chronic Obstructive Pulmonary Disease	22
Diabetes	38
Dementia	29
Cancer	14

hospital care	171
inpatient care	171

**Gender**
Male	31
Female	22

**Ethnicity**
Non-Hispanic White	34
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	21
From 75 to 84	15
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	72
Stroke	0
Ischemic Heart Disease	47
Depression	45
Chronic Kidney Disease	75
Asthma	0
Osteoperosis	0
Atrial Fibrilation	21
Heart Failure	47
Chronic Obstructive Pulmonary Disease	25
Diabetes	38
Dementia	0
Cancer	25

hospital care	250
inpatient care	250

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Stephanie Halene, MD for Medicare patients.

The highest averages for the top procedures that Dr. Stephanie Halene, MD treated as an adult hematologist in New Haven, CT were hospital care and inpatient care.

hospital care	245
inpatient care	245

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Stephanie Halene, MD.

**Gender**
Male	36
Female	37

**Ethnicity**
Black / African American	3
Asian / Pacific Islander	0
Non-Hispanic White	52
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
85 and over	2
75 to 84	13
Less than 65	12
65 to 74	29

Average of Total of Conditions of Medicare patients treated by Dr. Stephanie Halene, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Stephanie Halene, MD treated were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	60
High Cholesterol	46
Stroke	7
Ischemic Heart Disease	39
Depression	36
Chronic Kidney Disease	57
Asthma	10
Osteoporosis	0
Heart Failure	37
Chronic Obstructive Pulmonary Disease	21
Diabetes	29
Atrial Fibrillation	15
Dementia	16
Cancer	11

Education & Training

She completed residency at Yale-New Haven Hospital. She has a state license in Connecticut.

Residency: Yale-New Haven Hospital

Licensed In: Connecticut

Affiliations & Hospitals

Dr. Stephanie Halene, MD is associated with these hospitals and organizations:

Yale University

Yale New Haven Health

Smilow Cancer Hospital, Yale Medicine

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Stephanie Halene, MD appears to accept the following insurance providers: CorVel, Great-West Healthcare, WellCare, MultiPlan, Community Care Network (CCN), United Healthcare, Aetna, TRICARE, Oxford Health Plans, Medicare, Consumer Health Network, Medicaid, Humana, Cigna, Anthem, ConnectiCare, Focus Health Solutions, Prime Health, First Health, Private Healthcare Systems (PHCS), COMPWORKS, HEALTHCARE VALUE MANAGEMENT, MANAGED COMP, HUSKY and PREFERRED HEALTH WORKS.

Insurance Accepted by Provider includes:

According to our sources, Dr. Stephanie Halene, MD accepts the following insurance providers:

CorVel

Great-West Healthcare

WellCare

MultiPlan

Community Care Network (CCN)

United Healthcare

Aetna

TRICARE

Oxford Health Plans

Medicare

Consumer Health Network

Medicaid

Humana

Cigna

Anthem

ConnectiCare

Focus Health Solutions

Prime Health

First Health

Private Healthcare Systems (PHCS)

COMPWORKS

HEALTHCARE VALUE MANAGEMENT

MANAGED COMP

HUSKY

PREFERRED HEALTH WORKS

Show More

Ratings & Reviews

Dr. Stephanie Halene, MD does not have any reviews yet, be the first to leave a review of Dr. Stephanie Halene, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Stephanie Halene, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Alexion Pharmaceuticals, Inc.	$2,651 SOLIRIS $2,651
Regeneron Pharmaceuticals, Inc.	$736 $736
Merck Sharp & Dohme Corporation	$31 $31

**Types of Payments**
Consulting Fee	$2,400
Travel and Lodging	$510
Food and Beverage	$507

Biography

Dr. Stephanie Halene's specialty is adult hematology. Her clinical interests include myelodysplastic syndromes (MDS), leukemia, and thrombocytosis (high platelet count). She accepts Anthem, ConnectiCare, and Blue California, in addition to other insurance carriers. For her residency, Dr. Halene trained at Yale-New Haven Hospital. Dr. Halene (or staff) speaks Spanish, German, and French. She is professionally affiliated with Yale New Haven Health. Dr. Halene welcomes new patients at her office inNew Haven, CT as reported by Yale New Haven Health.